Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction

NCT06012448 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT06012448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06012448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction
Lead sponsor
University of Michigan
Phase
Phase 4
Overall status
Completed
Start date
October 2, 2023
Completion date
March 25, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermal hypersensitivity reaction